Insights into myelin dysfunction in schizophrenia and bipolar disorder

Area of Science:

• Neuroscience
• Psychiatry
• Cell Biology

Background:

• Schizophrenia and bipolar disorder affect ~1% of the global population, presenting chronic challenges.
• Both disorders share clinical and neurobiological similarities, including oligodendrocyte dysfunction and white matter alterations.
• These abnormalities may underlie disrupted brain connectivity crucial for cognitive and emotional functions.

Purpose of the Study:

• To review multilevel alterations in oligodendrocytes and white matter tracts in schizophrenia and bipolar disorder.
• To highlight the role of specific proteins in oligodendrogenesis and myelination.
• To explore the potential of targeting the axo-myelin unit for novel therapeutic strategies.

Main Methods:

• Review of existing literature on cellular and subcellular anomalies in oligodendrocytes and myelin.
• Analysis of neuroimaging findings on white matter tract alterations.
• Discussion of molecular components involved in oligodendrocyte function.

Main Results:

• Consistent evidence of oligodendrocyte and myelin abnormalities in postmortem brain samples.
• Neuroimaging reveals macroscale connectomic alterations in both disorders.
• Specific proteins are implicated in key oligodendroglial functions like myelination.

Conclusions:

• Oligodendroglial dysfunction and white matter tract alterations are significant features of schizophrenia and bipolar disorder.
• The molecular machinery of the axo-myelin unit presents promising targets for future therapeutic interventions.
• Understanding these neurobiological underpinnings is vital for developing effective treatments.